What does DR. MARLEEN SMET do?

DR. MARLEEN SMET is a specialist medical practice in Evergem. Private Limited, started on 16 June 2000.

What is the address of DR. MARLEEN SMET?

The registered office of DR. MARLEEN SMET is located at Schoonstraat 25, 9940 Evergem.

Is DR. MARLEEN SMET still active?

Yes. According to the CBE (31 October 2026) DR. MARLEEN SMET is active, legal situation “Normale toestand”, started on 16 June 2000.

Is DR. MARLEEN SMET registered on Peppol?

Yes, DR. MARLEEN SMET is registered on the Peppol network with ID 0208:0472133147.

What is the enterprise number of DR. MARLEEN SMET?

The enterprise number of DR. MARLEEN SMET is BE0472133147.

When was DR. MARLEEN SMET founded?

DR. MARLEEN SMET was founded on 16 June 2000.

Who are the directors of DR. MARLEEN SMET?

According to the 2026 annual accounts, the directors of DR. MARLEEN SMET are: Marleen SMET.

Is DR. MARLEEN SMET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 June 2000; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did DR. MARLEEN SMET make in 2026?

DR. MARLEEN SMET posted a profit after taxes of € 320,758 in financial year 2026.

What is the revenue of DR. MARLEEN SMET?

As a small company, DR. MARLEEN SMET is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 461,543.

DR. MARLEEN SMET (Private Limited) - Evergem

Dossier DR. MARLEEN SMET, printed on 31 October 2026 from databakkes.be/en/0472133147/dr-marleen-smet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

DR. MARLEEN SMET from Evergem, company number BE0472133147, closed financial year 2026 with a result of € 320,758 after tax. For that financial year DR. MARLEEN SMET recorded a gross margin of € 461,543 and equity of € 1.7 million. Compared with financial year 2025, the result moved from € 308,030 to € 320,758. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 10, 2026.

What it is worth Growing

€ 1.7 million

▲ 11% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 320,758

▲ 4% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 832,339

▲ 8% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 152,487 paid out

48 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2026

Vehicles and equipment

€ 34,603

▼ 27% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 485

▼ 4% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,742

▼ 72% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 381,598 Gross margin 2023: € 381,598 First fiscal year in the series	€ 418,451 Gross margin 2024: € 418,451 ▲ 10% vs 2023 (€ 381,598) Favourable step	€ 440,438 Gross margin 2025: € 440,438 ▲ 5% vs 2024 (€ 418,451) Favourable step	€ 461,543 Gross margin 2026: € 461,543 ▲ 5% vs 2025 (€ 440,438) Favourable step	▲ 5%
Profit after taxes	€ 262,996 Profit after taxes 2023: € 262,996 First fiscal year in the series	€ 289,988 Profit after taxes 2024: € 289,988 ▲ 10% vs 2023 (€ 262,996) Favourable step	€ 308,030 Profit after taxes 2025: € 308,030 ▲ 6% vs 2024 (€ 289,988) Favourable step	€ 320,758 Profit after taxes 2026: € 320,758 ▲ 4% vs 2025 (€ 308,030) Favourable step	▲ 4%
Equity	€ 1,068,106 Equity 2023: € 1,068,106 First fiscal year in the series	€ 1,189,016 Equity 2024: € 1,189,016 ▲ 11% vs 2023 (€ 1,068,106) Favourable step	€ 1,495,380 Equity 2025: € 1,495,380 ▲ 26% vs 2024 (€ 1,189,016) Favourable step	€ 1,663,651 Equity 2026: € 1,663,651 ▲ 11% vs 2025 (€ 1,495,380) Favourable step	▲ 11%
Total debts	€ 144,522 Total debts 2023: € 144,522 First fiscal year in the series	€ 192,848 Total debts 2024: € 192,848 ▲ 33% vs 2023 (€ 144,522) Unfavourable step	€ 47,397 Total debts 2025: € 47,397 ▼ 75% vs 2024 (€ 192,848) Favourable step	€ 15,362 Total debts 2026: € 15,362 ▼ 68% vs 2025 (€ 47,397) Favourable step	▼ 68%
Cash	€ 1,037,526 Cash 2023: € 1,037,526 First fiscal year in the series	€ 1,146,050 Cash 2024: € 1,146,050 ▲ 10% vs 2023 (€ 1,037,526) Favourable step	€ 771,560 Cash 2025: € 771,560 ▼ 33% vs 2024 (€ 1,146,050) Unfavourable step	€ 832,339 Cash 2026: € 832,339 ▲ 8% vs 2025 (€ 771,560) Favourable step	▲ 8%
Retained profit	€ 1,055,706 Retained profit 2023: € 1,055,706 First fiscal year in the series	€ 1,188,616 Retained profit 2024: € 1,188,616 ▲ 13% vs 2023 (€ 1,055,706) Favourable step	€ 1,494,980 Retained profit 2025: € 1,494,980 ▲ 26% vs 2024 (€ 1,188,616) Favourable step	€ 1,663,251 Retained profit 2026: € 1,663,251 ▲ 11% vs 2025 (€ 1,494,980) Favourable step	▲ 11%
Dividend	€ 120,878 Dividend 2023: € 120,878 First fiscal year in the series	€ 157,078 Dividend 2024: € 157,078 ▲ 30% vs 2023 (€ 120,878) Unchanged	€ 1,666 Dividend 2025: € 1,666 ▼ 99% vs 2024 (€ 157,078) Unchanged	€ 152,487 Dividend 2026: € 152,487 ▲ € 150,821 vs 2025 (€ 1,666) Unchanged	▲ € 150,821
Balance sheet total	€ 1,212,628 Balance sheet total 2023: € 1,212,628 First fiscal year in the series	€ 1,381,864 Balance sheet total 2024: € 1,381,864 ▲ 14% vs 2023 (€ 1,212,628) Unchanged	€ 1,542,777 Balance sheet total 2025: € 1,542,777 ▲ 12% vs 2024 (€ 1,381,864) Unchanged	€ 1,679,013 Balance sheet total 2026: € 1,679,013 ▲ 9% vs 2025 (€ 1,542,777) Unchanged	▲ 9%

Key figures of DR. MARLEEN SMET, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to DR. MARLEEN SMET?

What happened at DR. MARLEEN SMET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 10, 2026 New annual accounts for financial year 2026: profit of € 320,758 (▲ 4% vs 2025). Source: NBB ↗
Jun 16, 2000 Start of the company according to the CBE. KBO

In short

From € 262,996 profit in 2023 to € 320,758 profit in 2026.

Paid € 527,806 in corporate taxes since 2023.

Best year ever: 2026, with € 320,758 profit.

Paid out € 432,109 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Marleen SMET

DR. MARLEEN SMET

Behind DR. MARLEEN SMET is Marleen SMET.

Directors

According to the 2026 annual accounts

Marleen SMET

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Schoonstraat 25

9940 Evergem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0472.133.147

VAT number

BE 0472.133.147

Registered office

Schoonstraat 25, 9940 Evergem

Names & denominations

DR. MARLEEN SMET

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 June 2000

Peppol

Active · Active since 20 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Markt- en opinieonderzoek

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. MARLEEN SMET

Financials

What happened to DR. MARLEEN SMET?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions